ES2056928T3 - Compuestos heterociclicos. - Google Patents

Compuestos heterociclicos.

Info

Publication number
ES2056928T3
ES2056928T3 ES88304899T ES88304899T ES2056928T3 ES 2056928 T3 ES2056928 T3 ES 2056928T3 ES 88304899 T ES88304899 T ES 88304899T ES 88304899 T ES88304899 T ES 88304899T ES 2056928 T3 ES2056928 T3 ES 2056928T3
Authority
ES
Spain
Prior art keywords
acch
formula
cyclic compounds
hetero cyclic
hetero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88304899T
Other languages
English (en)
Inventor
Klaus Peter Bogeso
Klaus Gundertofte Jensen
Ejner Knud Moltzen
Pedersen Henrik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of ES2056928T3 publication Critical patent/ES2056928T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

COMPUESTOS HETEROCICLICOS DE LA FORMULA (I) DONDE LA LINEA DE PUNTOS DESIGNA UN ENLACE OPCIONAL Y "HET", R1, R2, R3, R4 Y R5 SON COMO SE REDEFINEN EN LA REIVINDICACION 1 ASI COMO ESTEREOISOMEROS INDIVIDUALES Y SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS QUE SON NUEVAS Y SE DESCRIBEN COMO POSEEDORAS DE UNA POTENTE ACTIVIDAD AGONISTA DE LA ACETILCOLINA (ACCH) INDICANDO UTILIDAD EN EL TRATAMIENTO DE ENFERMEDADES CAUSADAS POR LA REDUCCION DE LA FUNCION DE LA ACCH EN EL CEREBRO. SE DESCRIBEN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN UN COMPUESTO DE LA FORMULA (I) Y METODOS PARA LA PREPARACION DE ESTOS.
ES88304899T 1987-06-24 1988-05-27 Compuestos heterociclicos. Expired - Lifetime ES2056928T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878714789A GB8714789D0 (en) 1987-06-24 1987-06-24 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ES2056928T3 true ES2056928T3 (es) 1994-10-16

Family

ID=10619472

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88304899T Expired - Lifetime ES2056928T3 (es) 1987-06-24 1988-05-27 Compuestos heterociclicos.

Country Status (19)

Country Link
US (3) US4866077A (es)
EP (1) EP0296721B1 (es)
JP (1) JP2703268B2 (es)
AU (1) AU615917B2 (es)
BR (1) BR1100658A (es)
CA (1) CA1340458C (es)
DE (1) DE3881970T2 (es)
DK (1) DK168600B1 (es)
ES (1) ES2056928T3 (es)
FI (1) FI93356C (es)
GB (1) GB8714789D0 (es)
HK (1) HK84194A (es)
HU (1) HU210809A9 (es)
IE (1) IE61694B1 (es)
IL (1) IL86618A (es)
NO (1) NO174051C (es)
NZ (1) NZ224868A (es)
PT (1) PT87820B (es)
ZA (1) ZA884339B (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
DE68905845T2 (de) * 1988-02-19 1993-08-05 Lilly Co Eli Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
IT1229491B (it) * 1988-12-28 1991-09-03 Roussel Maestretti S P A Ora R Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
JP3003148B2 (ja) * 1989-01-05 2000-01-24 藤沢薬品工業株式会社 チアゾール化合物、その製造法およびそれを含有する医薬組成物
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
EP0402056A3 (en) * 1989-06-06 1991-09-04 Beecham Group p.l.c. Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
DE69026197T2 (de) * 1989-10-07 1997-01-09 Beecham Group Plc Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US5200419A (en) * 1990-05-21 1993-04-06 Warner-Lambert Company Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
IE911994A1 (en) * 1990-07-03 1992-01-15 Akzo Nv 5-isothiazolamine derivatives
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
USRE35822E (en) * 1990-08-21 1998-06-09 Novo Nordisk A/S Heterocyclic compounds
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
ATE164519T1 (de) * 1990-11-29 1998-04-15 Allergan Inc Verwendung von pyridine derivate zur behandlung der okulären hypertomie
AU654013B2 (en) * 1991-03-13 1994-10-20 Regents Of The University Of Minnesota 2-hydroxy-3(4-iodophenyl)-1-(4-phenylpiperidinyl) propane
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives
DE69325662T2 (de) * 1992-10-23 2000-02-10 Merck Sharp & Dohme Ltd., Hoddesdon Dopamin rezeptor subtyp liganden
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
US5612351A (en) * 1994-11-08 1997-03-18 Novo Nordisk A/S Method of treating urinary bladder dysfunctions
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
AU6299296A (en) * 1995-06-29 1997-01-30 Novo Nordisk A/S Novel substituted azacyclic compounds
AU706594B2 (en) * 1995-11-06 1999-06-17 H. Lundbeck A/S Treatment of traumatic brain injury
AU2568597A (en) * 1996-04-24 1997-11-12 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
ATE273007T1 (de) * 1997-05-29 2004-08-15 Lundbeck & Co As H Behandlung der schizophrenie und der psychose
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
AU9432498A (en) * 1997-10-02 1999-04-27 H. Lundbeck A/S Granular preparations of 5-(2-ethyl- 2(h)-tetrazol- 5-yl)-1-methyl-1, 2,3,6-tetrahydropyridine
WO2000006082A2 (en) * 1998-07-27 2000-02-10 Eli Lilly And Company Treatment of anxiety disorders
CO5440228A1 (es) * 1999-08-23 2004-09-30 Lunbeck As H Tratamiento de la incontinencia urinaria
US20030220371A1 (en) * 2000-04-12 2003-11-27 Kallander Lara S. Compounds and methods
AU2002253432B2 (en) * 2001-04-05 2005-03-24 Torrent Pharmaceuticals Ltd. Heterocyclic compounds for aging-related and diabetic vascular complications
US20030069597A1 (en) * 2001-10-10 2003-04-10 Scimed Life Systems, Inc. Loading tool
WO2003043987A2 (en) 2001-11-19 2003-05-30 Elan Pharmaceuticals, Inc. (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
BR0317324A (pt) 2002-12-18 2005-11-16 Fmc Corp N-(arilmetil substituìdo)-4-(metil dissubstituìdo) piperidinas e piridinas
EP1581497A4 (en) * 2002-12-20 2009-03-18 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
WO2005080394A1 (en) * 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
US20060224175A1 (en) * 2005-03-29 2006-10-05 Vrba Anthony C Methods and apparatuses for disposition of a medical device onto an elongate medical device
EP1928437A2 (en) * 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8084473B2 (en) 2007-04-24 2011-12-27 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors
JP2010525020A (ja) * 2007-04-24 2010-07-22 ソルベイ・フアーマシユーチカルズ・ベー・ブイ ムスカリン性受容体への親和性を有する複素環式化合物
US20110294835A1 (en) 2008-05-15 2011-12-01 The Board Of Trustees Of The University Of Illinois Muscarinic Agonists as Cognitive Enhancers
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CA2764232A1 (en) * 2009-05-07 2010-11-11 Torrent Pharmaceuticals Limited Novel heterocyclic compounds
WO2012007500A2 (de) 2010-07-15 2012-01-19 Bayer Cropscience Ag Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
WO2012052412A1 (de) 2010-10-22 2012-04-26 Bayer Cropscience Ag Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
US9549928B2 (en) 2011-04-29 2017-01-24 The University Of Toledo Muscarinic agonists as enhancers of cognitive flexibility
CN103848850B (zh) * 2013-08-28 2016-03-23 沈阳东瑞精细化工有限公司 一种舒巴坦的制备方法
US10857157B2 (en) 2015-01-26 2020-12-08 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US11198680B2 (en) 2016-12-21 2021-12-14 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10537567B2 (en) 2017-07-11 2020-01-21 BioAxone BioSciences, Inc. Kinase inhibitors for treatment of disease
EP4216949A4 (en) * 2020-09-28 2024-12-11 Yale University Selective agonists of 5-ht2a receptor and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2659739A (en) 1950-04-14 1953-11-17 Eastman Kodak Co 1-hydroxy-4-beta-cyanopropylamino-anthraquinone and process for preparing same
BE845612A (fr) * 1976-03-23 1977-02-28 Derives de tetrazole-5-carboxamide et leur preparation
US4431653A (en) * 1982-03-18 1984-02-14 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3421072A1 (de) * 1984-06-06 1985-12-12 Heinrich Mack Nachf., 7918 Illertissen 1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Substituted 1, 2, 4- oxadiazolyl piperidine compounds, their preparation and pharmaceutical compositions containing them
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
EP0372125A1 (en) * 1988-11-08 1990-06-13 Akzo N.V. Oxazole and thiazole derivatives

Also Published As

Publication number Publication date
NZ224868A (en) 1990-07-26
EP0296721A2 (en) 1988-12-28
IE881631L (en) 1988-12-24
DK168600B1 (da) 1994-05-02
PT87820A (pt) 1989-05-31
HK84194A (en) 1994-08-26
EP0296721B1 (en) 1993-06-23
AU615917B2 (en) 1991-10-17
CA1340458C (en) 1999-03-23
NO882799L (no) 1988-12-27
IL86618A0 (en) 1988-11-30
DK321688A (da) 1988-12-25
EP0296721A3 (en) 1990-04-25
USRE36374E (en) 1999-11-02
PT87820B (pt) 1992-10-30
GB8714789D0 (en) 1987-07-29
DE3881970T2 (de) 1993-11-11
ZA884339B (en) 1989-05-30
FI883064A7 (fi) 1988-12-25
NO174051C (no) 1994-03-09
DE3881970D1 (de) 1993-07-29
FI93356B (fi) 1994-12-15
JPS6422869A (en) 1989-01-25
NO174051B (no) 1993-11-29
BR1100658A (pt) 1999-08-31
FI93356C (fi) 1995-03-27
AU1828288A (en) 1989-01-05
FI883064A0 (fi) 1988-06-23
JP2703268B2 (ja) 1998-01-26
IE61694B1 (en) 1994-11-16
US4925858A (en) 1990-05-15
HU210809A9 (en) 1995-08-28
IL86618A (en) 1992-07-15
NO882799D0 (no) 1988-06-23
DK321688D0 (da) 1988-06-13
US4866077A (en) 1989-09-12

Similar Documents

Publication Publication Date Title
ES2056928T3 (es) Compuestos heterociclicos.
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
ES2158413T3 (es) Alquenoilguanididas sustituidas con fenilo, procedimiento para su preparacion, su uso como farmacos o en agentes de diagnostico y medicamentos que las contienen.
LU90155I2 (fr) Vistide - cidofovir 75 mg/ml
ES2256969T3 (es) Compuestos de benzotiazol inhibidores de proteina tirosina qauinasa.
ES2030777T3 (es) Un metodo para preparar un derivado de n-indanil-carboxamida, y fungicida agricola/horticola que contiene el derivado como ingrediente activo.
NL174250C (nl) Werkwijze ter bereiding van een fungicide preparaat door derivaten van n-benzyl n'-fenylurea of -thiourea als actief bestanddeel op te nemen in een drager, alsmede van de daarvoor geschikte derivaten van n-benzyl n'-fenylurea of -thiourea.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2011296B3 (es) Derivados de benzo[b]tiofeno y benzo [b]furano carboxamidas, sus procedimientos de preparacion y los medicamentos que los contienen.
ATE154802T1 (de) Liganden für dopaminerezeptoren und bilderzeugende mittel
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
MX169299B (es) Fluido de sondeo
ES8708218A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazina.
GT200000049A (es) Compuestos quimicos.
AR026338A1 (es) Dihidrotiazoles policiclicos, provistos en posicion 2 de radicales alquilo sustituidos, procedimiento para su preparacion y su utilizacion comomedicamentos
ES2009785B3 (es) Procedimiento para preparar derivados de tioxantona.
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
ES2071666T3 (es) Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MA19996A1 (fr) Procede de preparation de derives disubstitues de la proline
ES2072263T3 (es) Derivados de 4-aminopiridina.
MX9400070A (es) Compuestos heterociclicos, un procedimiento para prepararlos, su uso y composiciones farmaceuticas que los contienen.
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
MX168469B (es) Procedimiento para la preparacion de derivados aminoalcoholes acilados
ES2102043T3 (es) Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 296721

Country of ref document: ES